Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

NCT06333652 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Preeclampsia

Interventions

DRUG: Ravulizumab

Sponsor

Mayo Clinic